{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/5ef0acf44320b108b12f7e8b/6a4cc625e4f7d40f0635c848?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Symposium | Cytopenias in MF: Clinical burden and the need for prioritized management ","description":"<p>Hello, and welcome to our podcast. Today, Jean-Jacques Kiladjian, Consultant Hematologist from the Université Paris Cité - Hôpital Saint-Louis, Paris, France, discusses cytopenias in myelofibrosis, with a focus on clinical burden and the need for prioritized management.&nbsp;&nbsp;</p><p><br></p><p><em>This educational resource is independently supported by GSK. All content is developed by the faculty in collaboration with SES. Funders are allowed no influence.</em>&nbsp;</p>","author_name":"Scientific Education Support"}